Committee Testimony and Witness Signup
HB1230 - Public Health - Tianeptine Consumer Protection Act
Health and Government Operations 2/28/2024 1:00:00 PM
Finance 3/26/2024 1:00:00 PM
As of: 4/27/2024 3:10:12 AM
| Name | Organization | Position | Testimony | Committee |
|---|---|---|---|---|
| Delegate Pena-Melnyk, Delegate Pena-Melnyk | FAV |
In Person - Oral Testimony |
HGO | |
| Kalyanaraman, Nilesh | Maryland Department of Health | FWA |
In Person - Oral Testimony |
HGO |
| Alvey, Cynthia | FWA |
In Person - Oral Testimony Cindi WRITTEN Testimony Kratom and Tianeptine Feb |
HGO | |
| Forsyth, Heather | OAG/HEAU | FAV | HB1230.LOS.hf.20240226.pdf | HGO |
| Caplan, Jason | FWA | HB 1230 - HGO - PHPA - LOSWA.docx.pdf | HGO | |
| Delegate Pena-Melnyk, Delegate Pena-Melnyk | FAV |
In Person - Oral Testimony |
FIN | |
| Kalyanaraman, Nilesh | Maryland Department of Health | FWA |
In Person - Oral Testimony |
FIN |
| Caplan, Jason | FWA | 3 - HB 1230 - FIN - PHPA - LOSWA.docx (1).pdf | FIN | |
| Alvey, Jim | Self | FAV |
In Person - Oral Testimony Jim Testimony Tianeptine ONLY March 26 2024.pdf |
FIN |
| Rosen-Cohen, Nancy | NCADD-Maryland | FAV | NCADD-MD - 2024 HB 1230 FAV - Tianeptine - Senate. | FIN |
| Testimony, All | N/A | Merged Testimony as of 3-25-2024 at 841 PM | FIN |